Leap Therapeutics, a Nasdaq-listed biotech firm, has rebranded as Cypherpunk Technologies Inc, marking a strategic shift to focus on digital assets. The company has acquired 203,775.27 Zcash (ZEC) at an average price of $245 per coin, funded by a $58.88 million private placement led by Winklevoss Capital. Despite the pivot, Cypherpunk will retain its biotech operations and aims to enhance shareholder value through crypto asset allocation. The company's stock ticker will change to CYPH.